Reducing cardiovascular risk - are omega 3 fatty acids the solution?
DOI:
https://doi.org/10.12775/QS.2024.18.53426Keywords
omega-3 fatty acids, cardiovascular diseases, triglyceridesAbstract
Introduction and objective
Omega-3 fatty acids possess numerous physiological characteristics, including anti-inflammatory, lipid-lowering, antiarrhythmic, and antithrombotic effects. There has been an ongoing discussion about their potential positive effects on human health and the extent of their influence. In this review, we will explore the current understanding of how omega-3 fatty acids impact the development of cardiovascular diseases.
Review methods
A review of publications on the effects of omega 3 fatty acids was conducted using the PubMed platform. The main keywords used in the search were "omega 3 fatty acids" and "cardiovascular diseases". The search included a review of the latest scientific work on the effects of omega 3 fatty acids on the body.
Abbreviated description of the state of knowledge
Omega-3 fatty acids exhibit diverse molecular mechanisms that are beneficial in combating cardiovascular diseases. Reducing serum triglycerides is one of the ways in which omega 3 fatty acids have an advantageous effect on the cardiovascular system. Dietary sources and supplementation offer potential benefits.
Summary
Omega-3 fatty acids, including EPA and DHA, exhibit various molecular mechanisms such as antithrombotic, anti-inflammatory, and lipid-lowering effects, which are crucial in combating CVDs. Dietary sources of omega-3 include both animal and plant products. Supplementing with omega-3 fatty acids, particularly in patients with elevated triglyceride levels, can significantly reduce CVD risk factors and mortality rates. Recommendations suggest consuming 2 servings of fish per week or supplementing with DHA + EPA to support cardiovascular health. Despite some controversies in research findings, omega-3 supplementation remains beneficial. Ongoing research continues to explore the optimal use and efficacy of omega-3 fatty acids in cardiovascular health.
References
Townsend N, Kazakiewicz D, Lucy Wright F, et al. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19(2):133-143. doi:10.1038/s41569-021-00607-3
World Health Organization. Cardiovascular diseases (CVDs). In: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (dostęp 17.05.2024r)
Teo KK, Rafiq T. Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries. Can J Cardiol. 2021;37(5):733-743. doi:10.1016/j.cjca.2021.02.009
"Omega−3 Fatty Acids". Office of Dietary Supplements, US National Institutes of Health. 26 March 2021.
Cambiaggi L, Chakravarty A, Noureddine N, Hersberger M. The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases. Int J Mol Sci. 2023;24(7):6110. Published 2023 Mar 24. doi:10.3390/ijms24076110
Ruscica M, Sirtori CR, Carugo S, Calder PC, Corsini A. Omega-3 and cardiovascular prevention - Is this still a choice?. Pharmacol Res. 2022;182:106342. doi:10.1016/j.phrs.2022.106342
Shibabaw T. Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease. Mol Cell Biochem. 2021;476(2):993-1003. doi:10.1007/s11010-020-03965-7
Botts SR, Fish JE, Howe KL. Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment. Front Pharmacol. 2021;12:787541. Published 2021 Dec 22. doi:10.3389/fphar.2021.787541
Han SH, Nicholls SJ, Sakuma I, Zhao D, Koh KK. Hypertriglyceridemia and Cardiovascular Diseases: Revisited. Korean Circ J. 2016;46(2):135-144. doi:10.4070/kcj.2016.46.2.135
Han SH, Nicholls SJ, Sakuma I, Zhao D, Koh KK. Hypertriglyceridemia and Cardiovascular Diseases: Revisited. Korean Circ J. 2016;46(2):135-144. doi:10.4070/kcj.2016.46.2.135
Bornfeldt KE. Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines. J Clin Invest. 2021;131(6):e147558. doi:10.1172/JCI147558
Stroes ESG, Susekov AV, de Bruin TWA, Kvarnström M, Yang H, Davidson MH. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. J Clin Lipidol. 2018;12(2):321-330. doi:10.1016/j.jacl.2017.10.012
Scorletti E, Byrne CD (2013). "Omega−3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease". Annual Review of Nutrition. 33 (1): 231–248. doi:10.1146/annurev-nutr-071812-161230. PMID 23862644
Al-Madhagy S, Ashmawy NS, Mamdouh A, Eldahshan OA, Farag MA. A comprehensive review of the health benefits of flaxseed oil in relation to its chemical composition and comparison with other omega-3-rich oils. Eur J Med Res. 2023;28(1):240. Published 2023 Jul 18. doi:10.1186/s40001-023-01203-6
Djuricic I, Calder PC. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients. 2021;13(7):2421. Published 2021 Jul 15. doi:10.3390/nu13072421
Tomczyk M, Heileson JL, Babiarz M, Calder PC. Athletes Can Benefit from Increased Intake of EPA and DHA-Evaluating the Evidence. Nutrients. 2023;15(23):4925. Published 2023 Nov 26. doi:10.3390/nu15234925
Siscovick DS, Barringer TA, Fretts AM, et al. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation. 2017;135(15):e867-e884. doi:10.1161/CIR.0000000000000482
Harris WS, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides?. Curr Opin Lipidol. 2006;17(4):387-393. doi:10.1097/01.mol.0000236363.63840.16
Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902-907. doi:10.1161/CIRCULATIONAHA.108.191627
Santos HO, Price JC, Bueno AA. Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers-An Overview. Nutrients. 2020;12(10):3159. Published 2020 Oct 16. doi:10.3390/nu12103159
Shen S, Gong C, Jin K, Zhou L, Xiao Y, Ma L. Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials. Front Nutr. 2022;9:809311. Published 2022 Feb 3. doi:10.3389/fnut.2022.809311
Simopoulos AP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients. 2016;8(3):128. Published 2016 Mar 2. doi:10.3390/nu8030128
Baker EJ, Miles EA, Burdge GC, Yaqoob P, Calder PC. Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res. 2016;64:30-56. doi:10.1016/j.plipres.2016.07.002
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (European Heart Journal; 2021 — doi: 10.1093/eurheartj/ehab484).
Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. Circulation. 2019;140(12):e673-e691. doi:10.1161/CIR.0000000000000709
Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15(4):725-737. doi:10.1017/S1368980011002254
Bradley MA, Barst BD, Basu N. A Review of Mercury Bioavailability in Humans and Fish. Int J Environ Res Public Health. 2017;14(2):169. Published 2017 Feb 10. doi:10.3390/ijerph14020169
Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22. doi:10.1056/NEJMoa1812792
Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177. Published 2020 Feb 29. doi:10.1002/14651858.CD003177.pub5
Karalis DG. A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids. Adv Ther. 2017;34(2):300-323. doi:10.1007/s12325-016-0462-y
Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333. doi:10.1161/CIR.0b013e3182160726
Robinson JG, Stone NJ. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol. 2006;98(4A):39i-49i. doi:10.1016/j.amjcard.2005.12.026
Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits [published correction appears in JAMA. 2007 Feb 14;297(6):590]. JAMA. 2006;296(15):1885-1899. doi:10.1001/jama.296.15.1885
Huh JH, Jo SH. Omega-3 fatty acids and atrial fibrillation. Korean J Intern Med. 2023;38(3):282-289. doi:10.3904/kjim.2022.266
Xun P, Qin B, Song Y, et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2012;66(11):1199-1207. doi:10.1038/ejcn.2012.133
Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial [published correction appears in Stroke. 2008 Sep;39(9): e149]. Stroke. 2008;39(7):2052-2058. doi:10.1161/STROKEAHA.107.509455
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Julia Silldorff, Tomasz Fura, Marcin Dudek, Radosław Zaucha, Zuzanna Felińska, Oliwia Iszczuk, Stanisław Anczyk, Magdalena Gajkiewicz, Małgorzata Zając
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 112
Number of citations: 0